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Abstract: The glycoprotein uromodulin (UMOD) is the most abundant protein in human urine and
forms filamentous homopolymers that encapsulate and aggregate uropathogens, promoting pathogen
clearance by urine excretion. Despite its critical role in the innate immune response against urinary
tract infections, the structural basis and mechanism of UMOD polymerization remained unknown. Here,
we present the cryo-EM structure of the UMOD filament core at 3.5 Å resolution, comprised of the
bipartite zona pellucida (ZP) module in a helical arrangement with a rise of 65 Å and a twist of 180°.
The immunoglobulin-like ZPN and ZPC subdomains of each monomer are separated by a long linker
that interacts with the preceding ZPC and following ZPN subdomains by ฀-sheet complementation. The
unique filament architecture suggests an assembly mechanism in which subunit incorporation could be
synchronized with proteolytic cleavage of the C-terminal pro-peptide that anchors assembly-incompetent
UMOD precursors to the membrane.
DOI: https://doi.org/10.7554/elife.60265





Stanisich, Jessica J; Zyla, Dawid S; Afanasyev, Pavel; Xu, Jingwei; Kipp, Anne; Olinger, Eric; Devuyst,
Olivier; Pilhofer, Martin; Boehringer, Daniel; Glockshuber, Rudi (2020). The cryo-EM structure of the




The cryo-EM structure of the human uromodulin filament core reveals a 1 

























  7 
Affiliations 8 
1
 Institute of Molecular Biology & Biophysics, ETH Zurich, Otto-Stern-Weg 5, 8093 Zurich, 9 
Switzerland 10 
2
 Cryo-EM Knowledge Hub (CEMK), ETH Zurich, Otto-Stern-Weg 3, 8093 Zurich, Switzerland 11 
3
 Institute of Physiology, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, 12 
Switzerland 13 
4
 Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle 14 
University, Central Parkway, Newcastle upon Tyne, United Kingdom 15 
5
 Division of Nephrology, UCLouvain Medical School, Brussels, Belgium 16 
 17 
 18 
‡These authors contributed equally to this work 19 




The glycoprotein uromodulin (UMOD) is the most abundant protein in human urine and 22 
forms filamentous homopolymers that encapsulate and aggregate uropathogens, promoting 23 
pathogen clearance by urine excretion. Despite its critical role in the innate immune 24 
response against urinary tract infections, the structural basis and mechanism of UMOD 25 
polymerization remained unknown. Here, we present the cryo-EM structure of the UMOD 26 
filament core at 3.5 Å resolution, comprised of the bipartite zona pellucida (ZP) module in a 27 
helical arrangement with a rise of ~65 Å and a twist of ~180°. The immunoglobulin-like ZPN 28 
and ZPC subdomains of each monomer are separated by a long linker that interacts with the 29 
preceding ZPC and following ZPN subdomains by β-sheet complementation. The unique 30 
filament architecture suggests an assembly mechanism in which subunit incorporation could 31 
be synchronized with proteolytic cleavage of the C-terminal pro-peptide that anchors 32 
assembly-incompetent UMOD precursors to the membrane.  33 
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The most abundant protein in human urine, the glycoprotein uromodulin (UMOD; also 34 
Tamm-Horsfall protein, THP), is conserved throughout Mammalia and produced primarily in 35 
the epithelial cells lining the thick ascending limb (TAL) of the Henle loop in the kidney. 36 
There, UMOD is important for maintaining the water impermeable layer, regulating salt 37 
transport, and urinary concentration (Devuyst et al., 2017). Farther along the urinary tract, 38 
UMOD has been shown to act as a soluble adhesion antagonist against uropathogenic E. coli 39 
(UPEC) (Pak et al., 2001; Weiss et al., 2020).  40 
 41 
UMOD precursors traffic through the secretory pathway in the assembly incompetent pro-42 
UMOD form, where they become glycosylated at 8 potential N-glycosylation sites and 43 
eventually attached at the apical membrane surface via their glycosylphosphatidylinositol 44 
(GPI)-anchored C-terminal pro-peptide (CTP) (Rindler et al., 1990; Van Rooijen et al., 1999; 45 
Weiss et al., 2020). The protease hepsin then cleaves the CTP and UMOD assembles to 46 
homopolymeric filaments with an average length of 2.5 µm in the urine (Brunati et al., 2015; 47 
Porter and Tamm, 1955).  48 
 49 
Recently, the general architecture of the intrinsically flexible UMOD filaments was 50 
uncovered via cryo-electron tomography (Weiss et al., 2020). The results, together with 51 
previous data, showed that UMOD assembles to a zigzag shaped, linear polymer, where the 52 
core of the filament is formed by its bipartite zona pellucida (ZP) module with the 53 
subdomains ZPN and ZPC. The N-terminal domains, epidermal growth factor-like (EGF) I‒III 54 
and the following cysteine rich D8C domain, protrude as arms alternating from opposite 55 
sides of the filament, and the EGF IV domain connects the arms to the filament core (Figure 56 
1A) (Jovine et al., 2002; Schaeffer et al., 2009; Weiss et al., 2020). UMOD filaments 57 
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encapsulate piliated uropathogens through multivalent binding via their N-glycans to the 58 
lectins at the tips of bacterial pili. This mechanism not only prevents pathogen adhesion to 59 
target glycans on epithelial cells of the host, but also facilitates pathogen aggregation and 60 
clearance by urine excretion (Weiss et al., 2020).  61 
 62 
Despite these insights, the exact structural organization of UMOD filaments remained 63 
unknown. We set out to solve the structure of the UMOD filament by single-particle cryo-64 
EM. Isolated native UMOD filaments from a healthy individual appeared on the grid in two 65 
major views: a fishbone-like “front” view with alternately protruding arms, and a zigzag 66 
“side” view (Figure 1B). Marked conformational variation in both the filament core and the 67 
angles between the peripheral arms and the core was visible. Additionally, flexible N-glycans 68 
lining the filament core could be seen already in 2D class averages (Figure 1 – figure 69 
supplement 1). This intrinsic flexibility and glycan display is a prerequisite of pathogen 70 
encapsulation by UMOD filaments, however, they considerably complicated the structure 71 
determination by single-particle cryo-EM, restricting high-resolution analysis to the filament 72 
core. 73 
  74 
 Ab initio 3D reconstruction of 723,000 particles was followed by extensive classification and 75 
focused refinement together with the non-uniform refinement strategy in cryoSPARC in 76 
order to obtain a reconstruction of the UMOD core at 3.5 Å (Figure 1 – video 1). This high-77 
resolution, unsymmetrized map was used to rigid body fit the individual UMOD ZP 78 
subdomains, ZPN and ZPC, from the previously published crystal structure of a recombinant, 79 
assembly incompetent pro-UMOD fragment (consisting of the EGF IV domain, ZP module, 80 
and CTP (termed rEGF-ZP-CTP); Bokhove et al., 2016; PDB: 4WRN). The high-resolution of 81 
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the cryoSPARC map at the filament core allowed direct model building of the 82 
immunoglobulin-like (IG) ZP subdomain folds. The ZPN/ZPC asymmetric unit was then 83 
extended by rigid-body fitting within a lower resolution map (4.7 Å), refined in cisTEM, that 84 
contained more repeats. This fitting showed a helical architecture of the filament with a ~65 85 
Å rise and ~180° twist, which is consistent with parameters obtained by sub-tomogram 86 
averaging (Weiss et al., 2020). From here, we were able to ascertain an unexpected, 87 
extended conformation of the ZP monomers in the filament core, wherein a long, 28-88 
residue linker (UMOD residues L429‒F456) between the ZPN and ZPC subdomains of each 89 
ZP monomer spanned the ZPC from the previous module (ZPC-1) and the ZPN from the 90 
subsequent module (ZPN+1) (Figure 1C-D). The core region including the linker is well 91 
resolved, showing clear sidechain density (Figure 1 E-F). The linker between ZPN and ZPC of 92 
the monomers spans ~103 Å and interacts tightly with the two intervening ZP subdomains 93 
(Figure 1D‒F, Figure 1 ‒ figure supplement 2). Moreover, densities for prominent N-glycans 94 
at N396 and N513 were observed and allowed visualization of the core pentasaccharide and 95 
disaccharide, respectively (Figure 1C,D,G).   96 
 97 
The intrinsic flexibility of the UMOD fibers could be directly observed in the collected 98 
micrographs in the range of their curvatures (Figure 1B). Slight deviations in the helical rise 99 
along the chain and the intrinsic flexibility hampered particle classification and alignment 100 
and limited the resolution of the reconstructions. To analyze this flexibility, we measured 101 
the relative angles between subdomains after rigid-body docking into multiple, 102 
heterogeneous 3D class averages (Figure 1 – figure supplement 3). Similar maximum angular 103 
changes of ~7 degrees were obtained at both unique interfaces between the ZP 104 
subdomains, indicating that both interfaces equally give rise to the flexibility of the 105 
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filaments. Additionally, we utilized the 3D variability analysis from cryoSPARC (based on the 106 
principle component analysis (PCA); Punjani and Fleet, 2020),  which showed a similar 107 
degree of  filament bending (component 1) and an elongation of the filament along the z-108 
axis (component2) based on a relative rotation of ZP modules at the subdomain interfaces  109 
(Figure 1 – video 2).    110 
 111 
The elongated ZP linker establishes an intricate and extensively enchained scaffold for 112 
filament build-up from mature UMOD monomers. Reminiscent of donor strand 113 
complementation in subunit-subunit interactions of pili assembled via the chaperone-usher 114 
pathway or the more recently discovered type V pili (Shibata et al., 2020; Waksman, 2017), 115 
formation of the UMOD filament involves a -sheet complementation mechanism extending 116 
across enchained ZP modules (Figure 2A). Specifically, the extended linker between ZPN and 117 
ZPC in each monomer is comprised of 3 separate -strands: L1, L2, and L3 (residues 430‒118 
435, 438‒441, and 446‒452, respectively), where L1 and L2 of subunit n complement the 119 
fold of ZPC of subunit n‒1 (ZPC-1), and L3 extends the IG-fold of ZPN of subunit n+1 (ZPN+1) 120 
(Figure 2B). The complementation site (CS) between L1, L2, and ZPC-1 (denoted CSA) is 121 
formed by the antiparallel insertion of L1 relative to the ZPC F strand, and the shorter, 122 
parallel complementation of the ZPC A’ strand by the L2 strand (Figure 2C). L3, the 123 
longest -strand in the linker segment, binds parallel along the ZPN+1 G strand at 124 
complementation site B (CSB) (Figure 2D).  125 
 126 
The inter-molecular interface between the ZPN subdomain of subunit n and the ZPC domain 127 
of the preceding subunit (ZPC-1) (interface A, IA), is formed by mostly hydrophobic residues 128 
from both subunits (Figure 2E), creating a buried surface area of ~2000 Å2 (PISA server, 129 
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Krissinel and Henrick, 2007). Specifically, residues Y402, Y427, and L429 from ZPN at IA cover 130 
a prominent hydrophobic patch on the surface of the ZPC-1, composed of L491, F499, F456, 131 
and L570 (Figure 2 – figure supplement 1). The second unique intermolecular interface (IB) 132 
along the elongated UMOD monomer is formed between ZPC-1 and ZPN+1, and is spanned by 133 
the linker (Figure 2F). Surface charge complementary between the two ZP subdomains 134 
provides the basis for IB, highlighted by the insertion of R415 on ZPN+1 into a negatively 135 
charged pocket on ZPC-1 harboring D532. IB is further stabilized by hydrophobic interactions 136 
between ZPC-1 (F555, F553) ZPN+1 (I413, I414) and the linker (P441, V443) (Figure 2 – figure 137 
supplement 1). 138 
 139 
We utilized the Genome Aggregation Database (gnomAD) to parse missense variants in the 140 
UMOD ZP module detected in ~125,000 exome and ~15,000 whole-genome sequences from 141 
unrelated healthy individuals from various population studies (Karczewski et al., 2020). 142 
Given the selective pressure for high levels of functional UMOD filaments in the urine 143 
(Ghirotto et al., 2016), we reasoned that residues or regions of UMOD that are required for 144 
filament assembly should show less genetic variation in healthy individuals. Here, we found 145 
that both the linker segment and those residues important for creating IA and IB are 146 
relatively depleted in genetic variants, in contrast to the rest of the ZP module (Figure 2 – 147 
figure supplement 2; Supplementary file 1A). 148 
 149 
The previously reported structure of the pro-UMOD fragment rEGF-ZP-CTP, which 150 
crystallized as a homodimer in which only the ZPN subdomains interact (Bokhove et al., 151 
2016), provides the nearest comparison for the transition from pro-UMOD (CTP intact) to 152 
mature UMOD in the filament. Figure 3 shows the major conformational differences 153 
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between rEGF-ZP-CTP and the ZP module in the mature filament. The most prominent 154 
difference is the separation of ZPN and ZPC in the mature filament, where individual C 155 
atoms (e.g. ZPN residue S364) change their relative position by up to 95 Å (Figure 3A). In 156 
addition, formation of the 103 Å long linker segment in mature UMOD involves i) the 157 
excision of strand A from ZPC, which becomes the linker strand L3 in the mature ZP 158 
module, and ii) the unwinding and extension of the -helical segment connecting ZPN and 159 
ZPC in pro-UMOD that forms linker strands L1 and L2 in the mature ZP module (Figure 3B; 160 
Figure 3 – figure supplement 1). The overall folds of the ZPN and ZPC subdomains, however, 161 
remain the same (with C RMSD values of 2.0 and 1.2 Å, respectively). Notably, linker strand 162 
L2 occupies the same position in ZPC‒1 as the -strand segment (559‒605) from the CTP in 163 
rEGF-ZP-CTP. In the mature filament, the residues that constitute helix αEF of rEGF-ZP-CTP 164 
are extended and the involved aromatic residues undergo a rearrangement that allows 165 
binding of L2 (Figure 3 – figure supplement 2). In addition, the insertion of the linker strand 166 
L1 into ZPC-1 only becomes possible after the excision of its strand A, which blocks L1 167 
binding in rEGF-ZP-CTP (Figure 3C-E). Overall, the binding pocket for the CTP -strand in ZPC 168 
of rEGF-ZP-CTP is shorter than that accommodating L1 and L2 in the mature ZPC 169 
subdomain, causing a kink in the CTP peptide along the ZPC subdomain (Figure 3E). The 170 
difference observed in comparison of the ZPN domains is less dramatic; here, the same 171 
surface complemented by the rEGF-ZP-CTP strand G from the apposing ZPN in the crystal 172 
structure homodimer is fulfilled in the filament by the L3 strand from subunit n‒1 (Figure 173 
3F,G). 174 
 175 
The cryo-EM structure of the UMOD filament core raises the intriguing question of how 176 
UMOD filaments assemble from pro-UMOD subunits attached to the cell surface. Figure 4 177 
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shows the simplest conceivable model of UMOD filament assembly. Assembly requires the 178 
release of mature UMOD monomers from the membrane by proteolytic removal of the GPI-179 
anchored CTP by hepsin, thus making a ZPC module competent for binding the Lβ3 strand of 180 
another UMOD. Assembly starts by binding of a pro-UMOD ZPN module to strands Lβ1 and 181 
Lβ2 in a neighboring pro-UMOD (step 1). Hepsin cleavage may then occur at the elongating 182 
filament (step 2). Each subsequent UMOD incorporation step (steps 3, 4, etc.) would then be 183 
characterized by the intercalation of the ZPN from an incoming pro-UMOD between the two 184 
ZPC modules of the filament, leading to a more stable binding of the incoming ZPN 185 
compared to that in step 1. As a final cleavage step to release the assembled filaments from 186 
the membrane, a yet unidentified hydrolase may act upon UMOD, as small amounts of the 187 
CTP could still be detected in MS/MS spectra after trypsin digestion of mature filaments 188 
(Figure 4 – figure supplement 1). This UMOD assembly model is analogous to the recently 189 
proposed assembly mechanism of filamentous type V pili, in which assembly is linked with 190 
proteolytic release of pilus subunits from the outer bacterial membrane (Shibata et al., 191 
2020).  192 
 193 
The enchained -sheet complementation mechanism observed in the UMOD filament core 194 
may also be valid for other proteins containing membrane-anchored ZP modules and 195 
undergoing filament formation. For instance, another human ZP protein, alpha-tectorin 196 
(TECTA), forms filaments creating the basis for the apical extracellular matrix (ECM) on the 197 
cochlear supporting cells and shares important features with UMOD: a highly similar linker 198 
region and a conserved, C-terminal protease cleavage site (Figure 4 – figure supplement 2). 199 
Recently, Kim and colleagues proposed the “3D printing model” for surface-tethered, 200 
TECTA-mediated ECM organization (Kim et al., 2019), which is in agreement with our 201 
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proposed model of UMOD polymerization at the surface of TAL cells in the kidney tubule. 202 
Thus, the cryo-EM structure of the UMOD filament core might be representative for the 203 
core structure of multiple proteins with a C-terminal ZP module that become functional 204 
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Figure 1 338 
Cryo-EM structure of the human UMOD filament core. 339 
(A) Domain architecture of the membrane-anchored pro-UMOD monomer, composed of 4 340 
EGF-like domains (I-IV, gray), the cysteine-rich D8C domain (green), and the bipartite ZP 341 
module (ZPN and ZPC, blue). The fold of the C-terminal ZPC subdomain is extended by the 342 
GPI-anchored, C-terminal pro-peptide (CTP, red) that is cleaved by hepsin as a prerequisite 343 
of UMOD polymerization. The hepsin cleavage site (peptide bond 587‒588) is indicated by 344 
scissors. The previously crystallized UMOD segment rEGF-ZP-CTP is also indicated. The 345 
positions of the 8 verified N-glycosylation sites in mature UMOD filaments are indicated 346 
above the respective domains as hexagons (filled hexagons: complex type N-glycan; open 347 
hexagon: high mannose type N-glycan). Amino acid numbering according to pre-pro-UMOD 348 
including signal sequence. (B) Representative cryo-electron micrograph showing the two 349 
major views of UMOD filaments: front view (1) and side view (2). Scale bar: 50 nm. 350 
Schematic representations of the subdomain organization of these two views are shown on 351 
the right. (C) Segmented Coulomb potential map of the mature ZP module in the filament, 352 
shown over the low pass filtered reconstruction (at ~ 9 Å resolution, gray). The extended 353 
linker connecting ZPN and ZPC of the blue ZP module complements the folds of ZPN of the 354 
following and ZPC of the preceding ZP modules, (ZPN+1 and ZPC-1; plum and gold, 355 
respectively) by -sheet complementation. The map features show a helical rise of 65 Å and 356 
a twist of 180. The locations of the EGF IV and D8C domains from the filament arms are 357 
also indicated. The resolved N-glycan densities (dark grey) are indicated with arrows. (D) 358 
Front and side views of the refined model of the filament core within the obtained high 359 
resolution cryo-EM map. Resolved monosaccharide units of N-glycans are shown as gray 360 
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stick models. (E) Detailed view of the map features at selected regions in ZPN (plum) and 361 
ZPC (gold), illustrating the quality of the final cryo-EM model. (F) Contiguous Coulomb 362 
potential map (mesh) around the extended linker segment that harbors the -strands L‒363 
L3. L1 and L2 complement the ZPC fold of the preceding UMOD subunit, and L3 364 
complements ZPN of the following UMOD subunit. (G) Coulomb potential map around the 365 
core pentasaccharide of the complex type N-glycan attached to N396 in ZPN. Blue squares: 366 
N-acetylglucosamine; green circles: mannose.  367 
 368 
Figure 1 - figure supplement 1 369 
Cryo-EM data evaluation for UMOD fibers. 370 
(A) Fourier shell correlation (FSC) curves for the final high-resolution map from cryoSPARC 371 
including masked and “corrected” half-maps (3.47 Å at 0.143 FSC cut-off) and FSC curves for 372 
the refined model versus final map (3.99 Å at 0.5 FSC cut-off). FSC cut-off values are shown 373 
as black dotted lines. (B) FSC curves for the final map from cisTEM (4.70 Å at 0.143 FSC cut-374 
off, “corrected”). Half-map FSCs where calculated in cryoSPARC v2.  (C) Local resolution of 375 
the masked central part of the high-resolution cryoSPARC map used for the asymmetric unit 376 
of ZP module model building and refinement. (D) Local resolution of the masked cisTEM 377 
map used for the full ZP module refinement. (E) Local resolution visualization of the high-378 
resolution cryoSPARC map in the asymmetric unit. (F) Local resolution visualization of the 379 
cisTEM map. (G) Angular distribution plot from the high-resolution cryoSPARC map. Two 380 
preferred orientations are at ~20° and ~105°. (H) Distinct UMOD projections, including the 381 
rotation angles shown for the 3D volume projections (upper) and 2D classes (lower) indexed 382 
by the angular distribution in (B). Front and side views are the most observed orientations, 383 
as indicated in Figure 1. Glycans are indicated with white arrows.   384 
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Figure 1 - figure supplement 2 385 
Representative image of the high-resolution cryoSPARC Coulomb potential map fitted 386 
with the asymmetric unit (AU) UMOD model. 387 
Detailed view of the Coulomb potential map illustrating the quality of the main chain fitting. 388 
The Coulomb potential is visualized as a mesh at two different contour levels: 18 and 10 σ 389 
(red and blue, respectively). The linker region (ZPN, blue) spans the adjacent ZPC (gold), 390 
complementing the fold. 391 
 392 
Figure 1 - figure supplement 3 393 
Flexibility analysis of native UMOD filaments. 394 
(A) Individual ZP subdomains were rigid body docked into 3D class averages from different 395 
cryo-EM refinement packages (cryoSPARC and cisTEM). Once fitted, the positions of the 396 
subdomains were saved relative to one another to create a single UMOD polymer. A 397 
representative fit for the cisTEM map is shown, with the map in gray, individual ZP 398 
subdomains in black or blue (ZPN used for alignment). Four 3D class averages from 399 
cryoSPARC and five 3D class averages from cisTEM were used. (B) Models fitted into 3D 400 
class averages were aligned on the ZPN+1 subunit (blue). (C) Flexibility between the 401 
individual ZP subdomains is visualized as the maximum angle between subdomains at the 402 
same position, measured by comparing the fitted axes in Chimera. The farther from the 403 
aligned subdomain, the greater the observed ranges of relative angles, as the angular 404 
difference propagates along the chain.  405 
  406 
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Figure 2 407 
Inter-molecular-Sheet complementation in the ZP subdomains results in extensive 408 
interactions between neighboring subunits in the UMOD filament. 409 
(A) Cartoon representation of the ZP module of subunit n (blue) in complex with subdomain 410 
ZPN+1 (plum) and the subdomain ZPC-1 (gold) as surface representations. The total length of 411 
the polypeptide backbone of the extended 28-residue linker between ZPN and ZPC (stick 412 
representation) is approximately 103 Å. The -sheet complementation sites CSA, between 413 
the linker strands L1/L2 and ZPC‒1, and CSB, between linker strand L3 and ZPN+1, as well 414 
as the interfaces between the subdomains ZPN and ZPC-1 (interface IA) and ZPN+1 and ZPC 415 
(interface IB) are indicated. (B) Topology model indicating secondary structure elements of 416 
mature UMOD filaments based on the solved cryo-EM structure. (C) Complementation site 417 
A (CSA): the linker strands L1 and L2 complement the incomplete fold of ZPC-1 by 418 
interacting with its strand F and A’, respectively.  419 
(D) Complementation site B (CSB): the linker strand L3 complementing the fold of ZPN+1 by 420 
interaction with its strand A. (E) Interface A (IA) between ZPNn (blue) and ZPC‒1 (gold) 421 
showing extensive intermolecular hydrophobic interactions between the subdomains. 422 
Residues forming the interface are shown as sticks and labeled with the corresponding 423 
residue numbers (same color code as in A). (F) Interface B (IB) between ZPC‒1 (gold), ZPN+1 424 
(plum) and the linker peptide (blue) is stabilized by electrostatic and hydrophobic 425 
interactions. Loops of the ZP subdomains meet as a coupler with the linker spanning across.  426 
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Figure 2 - figure supplement 1 427 
UMOD ZP module interfaces are stabilized by hydrophobic packing. 428 
(A) Interface A (IA) colored by hydrophobicity of residues (based on the Eisenberg scale of 429 
hydrophobicity; dark red = most hydrophobic, white = least hydrophobic). Residue labels are 430 
colored by subdomain (as in Figure 2). (B) Interface B (IB) colored by hydrophobicity of 431 
residues, as in (A). Residue labels are colored by subdomain (as in Figure 2).  432 
 433 
Figure 2 – figure supplement 2 434 
gnomAD zero variance residues of the mature UMOD fiber linker region.  435 
Residues along the ZP linker are not highly variant in the gnomAD database of 125,748 436 
exomes and 15,708 genomes from unique unrelated individuals with high-quality sequence 437 
data (Karczewski et al., 2020). The linker residues between ZPN and ZPC of a UMOD subunit 438 
are shown as sticks and colored according to their score on a normalized PAM250 matrix. 439 
The complete amino acid sequence of the linker (UMOD residues 429‒456) is indicated 440 
below the structure of the UMOD monomer. Residues that show no variance within the 441 
gnomAD cohort are depicted in dark blue and boxed. Increasing variance, weighted 442 
according to the PAM250 matrix for allowed amino acid substitutions, is colored along a 443 
normalized spectrum from dark blue to dark red. ZPN and ZPC subdomains are shown in 444 
gray. The variance for each section of the ZP module is indicated above. 445 
  446 
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Figure 3 447 
Comparison of ZP module structure in the native filament to that in the crystal structure 448 
of rEGF-ZP-CTP. 449 
(A) Superposition of the structure of ZP module in the rEGF-ZP-CTP homodimer (gray, PDB: 450 
4WRN) with the solved cryo-EM structure of the mature ZP module in the filament (blue). 451 
Both structures were aligned via the ZPC subdomains. In the filament, the ZPN subdomain is 452 
shifted away from the ZPC subdomain of the same subunit by ~60 Å. (B) Rearrangement of 453 
secondary structure elements in ZPN and ZPC forming the extended linker upon UMOD 454 
polymerization compared to rEGF-ZP-CTP. The cryo-EM model of mature UMOD core is 455 
shown in blue, and the X-ray structure of rEGF-ZP-CTP (PDB: 4WRN) in gray. The CTP (absent 456 
in the mature filament) is highlighted in red. Left: The -helical segment at the C-terminus 457 
of ZPN in pro-UMOD forms the linker strands L1 and L2 in the mature filament. Right: The 458 
N-terminal ZPC -strand (A) in pro-UMOD forms the strand L3 in the extended linker of the 459 
mature filament. The CTP (red), providing the last ZPC -strand (G) in pro-UMOD. The 460 
hepsin cleavage site in pro-UMOD is circled. (C) Surface representation of the ZPC 461 
subdomain (gold) with the two complementing strands L1 and L2 from the following 462 
subunit. Labeled residues indicate the beginning and the end of Lβ1-2. (D) Superposition of 463 
the C-terminal pro-peptide forming pro-UMOD ZPC strand G (red) with the linker strands 464 
L1 and L2 (blue) that occupy the same hydrophobic groove in the polymer ZPC. Similar or 465 
identical hydrophobic -strand side chains are bound to the hydrophobic side chain pockets 466 
in ZPC (grey) in both structures. (E) Binding groove of pro-UMOD CTP (red, sticks) on the ZPC 467 
(gray surface. The N-terminal ZPC strand A (yellow outline) limits the size of the binding 468 
pocket. The βA strand is flipped out upon conformational change from pro-UMOD mature 469 
UMOD (then Lβ3).  (F) Structure of the crystallized ZPN homodimer of pro-UMOD (PDB: 470 
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4WRN). The N-terminal strand A of each ZPN subdomain interacts with the C-terminal G 471 
strand of the opposite ZPN. (G) In the UMOD polymer, ZPN G interacts with linker strand 472 
L3 (blue) instead, which occupies the same position as strand A (black) from the apposing 473 
subunit in the dimer. 474 
 475 
Figure 3 - figure supplement 1 476 
Regular secondary structure topology diagrams for the ZP modules. 477 
(A) Crystallized rEGF-ZP-CTP fragment (PDB: 4WRN; Bokhove et al., 2016). (B) Cryo-EM 478 
structure of the native UMOD filament. 479 
 480 
Figure 3 - figure supplement 2 481 
Rearrangement of aromatic residues at interface IB. 482 
Rearrangement of the aromatic residues from ZPC-1 at IB in the mature filament that change 483 
their position relative to the rEGF-ZP-CTP structure. Compared to rEGF-ZP-CTP, the helix αEF 484 
elongates, resulting in significant reorganizing of F553 and F555, and flipping of the Y520 485 
side chain. In rEGF-ZP-CTP, R606 on the CTP occupies a groove on αEF, but this interaction is 486 
eliminated in the native UMOD filament.  487 
 488 
Figure 4 489 
Proposed model of UMOD polymerization after hepsin cleavage of pro-UMOD.  490 
UMOD arms with the domains EGF I-III, D8C, and EGF IV are shown transparent to indicate 491 
their positions relative to the ZP domains. (Step 1) Binding of ZPN from a pro-UMOD 492 
monomer (blue) to the L3 segment of an extended neighbor pro-UMOD (gold) may start 493 
the assembly. (Step 2) In the resulting, asymmetric pro-UMOD dimer, hepsin (red scissors) 494 
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cleaves the GPI anchored CTP (red) from the ZPC subdomain. The released ZPC subdomain 495 
then binds to L1 and L2 of the incoming pro-UMOD. (Step 3) ZPN from a third pro-UMOD 496 
(plum) binds to the L3 segment between the two ZPC segments of the growing filament. 497 
(Step 4) Again, hepsin cleaves off the CTP from the pro-UMOD in which the ZPC is 498 
complexed with ZPN. Steps 3 and 4 are consistently repeated until filament assembly is 499 
completed.  500 
 501 
Figure 4 - figure supplement 1 502 
MALDI-MS/MS analysis of tryptic peptides of mature human UMOD filaments.  503 
After purification and tryptic digest, reduced, alkylated UMOD peptides were analyzed by 504 
MALDI-MS/MS. The UMOD signal sequence is boxed in purple, the CTP in red, and the GPI 505 
anchor attachment site is indicated with a red arrow. UMOD sequence segments confirmed 506 
by tryptic peptides are shown with a yellow background. The two detected C-terminal 507 
peptides 591-SGSVIDQSR-597 and 598-VLNLGPITR-606 belong to the CTP. This could hint at 508 
a hydrolase other than hepsin that releases the growing UMOD filament from the 509 
membrane by removal of the GPI anchor from the CTP in the lastly incorporated subunit. 510 
Identified peptides are highlighted in yellow, oxidized methionine residues are highlighted in 511 
green.  512 
 513 
Figure 4 - figure supplement 2 514 
Amino acid sequence alignment of ZP-containing, GPI anchored human proteins. 515 
A subset of human ZP-containing proteins can be predicted to form filaments based on their 516 
sequence similarity to UMOD. Glycoprotein 2 (GP2) has a high overall sequence similarity to 517 
UMOD and is a transcytotic receptor on specialized M cells in the gut for type 1 piliated 518 
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bacteria (Hase et al., 2009). GP2 has been shown to convert from a longer, membrane 519 
bound glycoprotein to a soluble glycoprotein with lower apparent molecular mass (Havinga 520 
et al., 1985), and from its similarity with UMOD we predict it also forms homopolymers of a 521 
similar type. In the extracellular matrix (ECM) that covers the cochlear epithelium, alpha-522 
tectorin (TECTA) builds up via its ZP domains and must be tethered to the cell surface for the 523 
ECM to form correctly (Kim et al., 2019). In contrast, the membrane glycoprotein endoglin 524 
(EGLN) also contains a ZP module, but is known to not form fibers. This is consistent with 525 
the complete lack of a linker region in EGLN (Saito et al., 2017).  526 
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Supplementary Materials 527 
Materials and Methods 528 
Purification of Human UMOD 529 
Human UMOD fibers were purified from a healthy donor as described in Weiss et al., 2020. 530 
Briefly, urine was purified using a diatomaceous earth filter, concentrated, and dialyzed 531 
overnight against 0.5 mM EDTA-NaOH, pH 8.2 (300 kDa cut-off, Spectrum laboratories). 532 
Aliquots were flash-frozen in liquid nitrogen and stored at ‒20°C until further use. Only the 533 
second morning micturition was utilized for urine collection. Protein concentrations were 534 
determined as previously described (Weiss et al., 2020). 535 
 536 
Cryo-EM Data Collection 537 
Protein samples (3.5 µL of 2.5 µM UMOD) were applied to a glow-discharged lacey carbon 538 
grids with an ultrathin carbon coating (Electron Microscopy Sciences) automatically blotted 539 
from the back side of the grid for 13.5 s (100% humidity, 9°C) and plunge frozen in liquid-540 
ethane-propane using a Vitrobot Mark IV (Thermo Fisher Scientific). Micrographs were 541 
acquired on a Titan Krios microscope (Thermo Fisher Scientific) operated at 300 kV with a 542 
Gatan K2 Summit direct electron detector using a slit width of 20 eV on a GIF-Quantum 543 
energy filter. A total of 4679 and 4864 movies were recorded over two data collections from 544 
two separate grids and subsequently merged. Images were recorded with EPU software 545 
(Thermo Fisher Scientific) at 130 000 x nominal magnification in counting mode with a 546 
calibrated pixel size of 1.084 Å. The defocus target ranges were -1.2 µm to -3.3 µm and -0.8 547 
µm to -2.0 µm for the first and second data collection, respectively. Each micrograph was 548 
dose-fractionated to 40 frames under a dose rate of 7.5 e- / Å / s, with an exposure time of 6 549 
s, resulting in a total dose of approximately 45 e- / Å2.  550 
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Cryo-EM Image Processing  551 
The collected movies were motion corrected with MotionCor2 (Zheng et al., 2017). The CTF 552 
parameters of the micrographs were estimated using Gctf 1.06 (Zhang, 2016). Following 553 
steps of image processing were done in cryoSPARC v2.15 (Punjani et al., 2017) and with the 554 
in-house written python scripts for data administration and interpretation 555 
(https://github.com/dzyla/umod_processing_scripts). Approximately 600 particles were 556 
manually picked from a random selection of micrographs and used to train a convolutional 557 
neural network picking model for TOPAZ (Bepler et al., 2019). A total of 1.3 million particles 558 
were picked via TOPAZ from all micrographs. For the first steps of processing, particles were 559 
extracted with 320 px box size and binned to 2.71 Å/px. After several rounds of 2D 560 
classification, 723,000 particles, corresponding to well resolved, clear classes, were selected 561 
for further processing. Three ab initio initial models were generated and a single best one 562 
was used as a 3D-reference for the 3D-heterogeneous refinement. 3D-heterogeneous 563 
refinement with 10 classes resulted in multiple distinct 3D class-averages, showing intrinsic 564 
flexibility of the specimen. The most populated 3D class-average of 145,000 particles was 565 
chosen for further refinements. Particles from selected class were then re-extracted at the 566 
original pixel size and subjected to a 3D-homogenous refinement. A mask was created in 567 
UCSF Chimera (Pettersen et al., 2004) for the center segments of 3D-reconstruction and 568 
used for several rounds of local refinement using a non-uniform refinement strategy. This 569 
pipeline yielded high resolution 3D-reconstruction of the central asymmetric unit (AU; ZPN, 570 
ZPC, and their complementing donor strands) at 3.5 Å. Detailed workflows are shown in 571 
Figure 1-figure supplement 1, Supplementary file 1B,C.  572 
To obtain a map focused on several repeat units, an alternative approach was applied using 573 
cisTEM for refinement and classification: all micrographs were manually selected, resulting 574 
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in a total of 8543 movies which were then also motion corrected using MotionCor2, CFT 575 
values estimated using Gctf, and 485,000 particles were manually picked as helices from a 576 
random selection of 3600 micrographs in RELION v3.0.8 (Zivanov et al., 2018) and extracted 577 
at the original pixel size. The particle stack was then subjected to 2D-classification in cisTEM 578 
(Grant et al., 2018). 402,000 good particles were selected, and multiple rounds of focused 579 
classification was performed with the imported best cryoSPARC 3D class-average as a 580 
reference (described above) and a spherical (120 Å radius) mask. Two of the resulting 3D 581 
class-averages were merged and another round of 3D-classification with the same spherical 582 
mask was undertaken, resulting in a map resolved to 4.7 Å from 330,000 particles. Map was 583 
filtered to 4.7 Å and sharpened using cisTEM default settings (pre-cut-off B-Factor -90.0, 584 
resolution cut-off 4.7 Å). Reported helical parameters were estimated in real space from the 585 
cisTEM map using relion_helix_toolbox (He and Scheres, 2017) with search ranges for rise 586 
(60‒67 Å) and twist (175–185°). Schematic workflows and details are shown in Figure 1 - 587 
figure supplement 1, Supplementary file 1B,D. For comparative purposes, the cisTEM map 588 
FSC curves and the local resolution maps were calculated in cryoSPARC for all generated 589 
half-maps.  590 
 591 
Model Building and Structure Refinement 592 
The individual ZP subdomains of the UMOD crystal structure (PDB: 4WRN;(Bokhove et al., 593 
2016)) were used as initial models (ZPN: aa 428-528, ZPC: aa 541-710, according to the 594 
4WRN numbering). First, the individual domains were rigid-body fitted to the map obtained 595 
in cryoSPARC using UCSF Chimera, followed by manual building in Coot 0.9 and ISOLDE 596 
(Croll, 2018; Emsley et al., 2010). The asymmetric unit (AU, defined as a single ZPN and ZPC 597 
and the inset linker) of UMOD was refined using phenix.real_space_refine program (Adams 598 
29 
 
et al., 2010) with the default settings, which apply Ramachandran restraints. To reduce the 599 
clashes between subunit interfaces, the AU model was used to create a model with 4 600 
consecutive ZP subdomains and was refined against the cisTEM map. The structure of the 601 
UMOD ZP module was then applied to the RosettaCM refinement with the symmetry 602 
derived from the cisTEM map (Song et al., 2013), with the “auto” strategy applied in the 603 
refinement. The central ZPN/ZPC module in the refined structure was manually adjusted to 604 
the high-resolution cryoSPARC map in COOT and was subsequently used to generate the 605 
final UMOD model. This updated model was subjected to the next round of RosettaCM 606 
refinement, with a higher RMS model restraint applied (r.m.s. = 0.2). Overall, three rounds 607 
of interactive manual and RosettaCM refinements were performed and the geometry 608 
parameter of final AU model structure was further improved using phenix.real_space_refine 609 
with tight reference restraints (sigma = 0.025). The side chain residues 462‒473 in AU model 610 
could not be built with confidence and were omitted from the final model.  611 
For the final model of the UMOD filament, a structure was generated with 3 copies of the 612 
final AU model by applying the symmetry derived from the cisTEM map. The central 613 
ZPN/ZPC subunit of the core part of the structures were subjected to a real space 614 
refinement with tight reference restraints (sigma = 0.025) using the cryoSPARC map. The 615 
center ZPN/ZPC subunit in the refined model was then used to generate the new UMOD 616 
filament structure. Clashes in the subunit interface were further reduced by performing 617 
another round of phenix.real_space_refine with tighter reference restraints (sigma = 0.02). 618 
Model validations were performed using Comprehensive Validation tool in PHENIX. Final 619 
model statistics were generated using MolProbity tool via PHENIX (Chen et al., 2010). 620 
Figures of the structure were prepared with PyMol v2.4 (The PyMOL Molecular Graphics 621 
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System, Version 2.4 Schrödinger, LLC) and EM map figures were generated with UCSF 622 
ChimeraX 0.93 (Goddard et al., 2018). 623 
Cryo-EM Model 3D Flexibility Analysis  624 
The well resolved reconstructions from 3D classifications steps performed independently in 625 
cryoSPARC and cisTEM were rigid-body fitted with ZP subdomains derived from the final 626 
model. Each subdomain was first placed at the correct position and then fitted by the Fit in 627 
Map tool in Chimera 1.13.1. In total, 6 ZP subdomains were fitted into 9 maps where the 628 
subdomain Coulomb potential was well defined (4 classes from cryoSPARC and 5 classes 629 
from cisTEM) and saved with fixed positions to each other as a “filament”. Next, using 630 
PyMOL align command, all 9 filament structures were aligned to the center ZPN subdomain. 631 
In Chimera, the define axis command was used to give each subunit a centroid and a central 632 
axis. For subunits at positions ZPC-1 and ZPC, the maximum angle was determined with the 633 
angle command.  634 
 635 
3D variability analysis of UMOD 636 
3D variability analysis (3DVA) was performed in cryoSPARC using ~723,000 particles 637 
extracted at the pixel size of 4.34 Å, 10 modes, and filter resolution of 9.2 Å. The 3DVA 638 
display job was run in the simple output mode with 20 intermediate frames. From 10 639 
generated components, the first two exhibited the same yaw/pitch movement (Figure 1 – 640 
video 2), the third showed an artifact at the box edge, and the fourth showed the elongation 641 
along the filament axis (Figure 1 – video 2). The higher components showed various 642 
movements in the arms (not shown).  643 
 644 
Assessing genetic variation using gnomAD 645 
31 
 
Genome Aggregation Database (GnomAD) v2.1.1 (https://gnomad.broadinstitute.org/) is 646 
aligned against the GRCh37 genome build and was released in March 2019. The dataset 647 
comprises 125,748 exomes and 15,708 genomes sequenced as part of various disease-648 
specific and population genetic studies, totaling 141,456 unrelated individuals from 8 major 649 
populations (Karczewski et al., 2020). Results for UMOD were filtered for missense variants 650 
and checked for consistency with the UMOD transcript ENST00000302509.8. Missense 651 
variants corresponding to a non-canonical transcript were manually removed. 652 
UMOD variants were parsed using an in-house Python script 653 
(https://github.com/dzyla/umod_processing_scripts) and plotted on the structure. Residues 654 
with no mutations were set to 1.0 and for all non-zero variants the values were normalized 655 
between 0 and 1, based on the PAM250 matrix. Structure was visualized by spectrum 656 
coloring in PyMOL 2.4. For Supplementary file 1A, all linker residues are shown and the 657 
interfaces are defined by atoms that are within 8 Å of one another, as defined by 658 
COCOMAPS (Vangone et al., 2011).  659 
32 
 
Supplementary Figures and Files 660 
Figure 1 - figure supplement 1: Cryo-EM data evaluation for UMOD fibers. 661 
Figure 1 - figure supplement 2: Representative image of the high-resolution cryoSPARC 662 
Coulomb potential map fitted with the asymmetric unit (AU) UMOD model. 663 
Figure 1 - figure supplement 3: Flexibility analysis of native UMOD filaments. 664 
Figure 1 - video 1: Cryo-EM map of a native UMOD filament. Identified surface N-glycans are 665 
highlighted (complex-type, blue; high mannose, green).  666 
Figure 1 - video 2: 3D variability analysis of UMOD filaments. Results of 3D Variability 667 
(3DVA) analysis performed in cryoSPARC on ~723,000 particles. Particles were subjected to 668 
10-dimentional analysis and two major distinct movements identified by the 3DVA analysis 669 
are shown as Variability component 1 (A) and 2 (B). Maps generated by 3DVA are shown at 670 
the minimum (blue) and maximum (red) values of each variability component. (A) 671 
Component 1 describes the yaw and pitch movement of UMOD filament along the filament 672 
axis similar to the movement described by the 3D classification. Major motion axes are 673 
indicated with dotted lines. (B) Component 2 resolved the UMOD elongation movement 674 
along the filament axis. 675 
 676 
Figure 2 - figure supplement 1: UMOD ZP module interfaces are stabilized by hydrophobic 677 
packing. 678 
Figure 2 – figure supplement 2: gnomAD zero variance residues of the mature UMOD fiber 679 




Figure 3 - figure supplement 1: Regular secondary structure topology diagrams for the ZP 682 
modules in the crystallized rEGF-ZP-CTP fragment and the cryo-EM structure of the native 683 
UMOD filament. 684 
Figure 3 - figure supplement 2: Rearrangement of aromatic residues at IB. 685 
 686 
Figure 4 - figure supplement 1: MALDI-MS/MS analysis of tryptic peptides of mature human 687 
UMOD filaments.  688 
Figure 4 - figure supplement 2: Amino acid sequence alignment of ZP-containing, GPI 689 
anchored human proteins. 690 
 691 
Supplementary file 1A: ZP module linker and interface amino acid positions with known 692 
variants (gnomAD). 693 
Supplementary file 1B: Cryo-EM data collection and model refinement statistics 694 
Supplementary file 1C: Flowchart for cryoSPARC cryo-EM processing. 695 
Supplementary file 1D: Flowchart for cisTEM cryo-EM processing. 696 













